GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer (Q34544893)

2 August 2017

1 reference

title

GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer (English)

1 reference

Srinivasan Yegnasubramanian

2 August 2017

0 references

1 reference

1 reference

1 reference

Angelo M De Marzo

5

0 references

series ordinal

3

object named as

Srinivasan Yegnasubramanian

1 reference

2 August 2017

2

Mark L Gonzalgo

1 reference

2 August 2017

Masashi Nakayama

1

1 reference

PubMed ID

14755684

2 August 2017

Xiaohui Lin

series ordinal

4

1 reference

PubMed ID

14755684

2 August 2017

William G Nelson

series ordinal

6

1 reference

2 August 2017

1 February 2004

1 reference

Journal of Cellular Biochemistry

2 August 2017

1 reference

2 August 2017

91

1 reference

2 August 2017

540-552

1 reference

2 August 2017

3

1 reference

Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force

2 August 2017

1 reference

Identification and characterization of a family of mammalian methyl-CpG binding proteins

21 January 2018

1 reference

Analysis of cooked muscle meats for heterocyclic aromatic amine carcinogens.

21 January 2018

1 reference

GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells

21 January 2018

1 reference

Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-captur

21 January 2018

1 reference

p63 is a prostate basal cell marker and is required for prostate development

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCB.10740

1 reference

2 August 2017

1 reference

PubMed ID

14755684